BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31281163)

  • 41. Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.
    Dalle JH; Peffault de Latour R
    Int J Hematol; 2016 Apr; 103(4):373-9. PubMed ID: 26872907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation.
    Dietz AC; Mehta PA; Vlachos A; Savage SA; Bresters D; Tolar J; Boulad F; Dalle JH; Bonfim C; de la Fuente J; Duncan CN; Baker KS; Pulsipher MA; Lipton JM; Wagner JE; Alter BP
    Biol Blood Marrow Transplant; 2017 May; 23(5):726-735. PubMed ID: 28115275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genomic characterization of the inherited bone marrow failure syndromes.
    Khincha PP; Savage SA
    Semin Hematol; 2013 Oct; 50(4):333-47. PubMed ID: 24246701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of immunogenetic polymorphisms in bone marrow failure syndromes.
    Serio B; Selleri C; Maciejewski JP
    Mini Rev Med Chem; 2011 Jun; 11(6):544-52. PubMed ID: 21561401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-RAS gene mutation in patients with aplastic anemia and aplastic anemia/ paroxysmal nocturnal hemoglobinuria during evolution to clonal disease.
    Mortazavi Y; Tooze JA; Gordon-Smith EC; Rutherford TR
    Blood; 2000 Jan; 95(2):646-50. PubMed ID: 10627475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study.
    Alter BP; Giri N; Savage SA; Peters JA; Loud JT; Leathwood L; Carr AG; Greene MH; Rosenberg PS
    Br J Haematol; 2010 Jul; 150(2):179-88. PubMed ID: 20507306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up.
    Alter BP; Giri N; Savage SA; Rosenberg PS
    Haematologica; 2018 Jan; 103(1):30-39. PubMed ID: 29051281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.
    Davidsson J; Puschmann A; TedgÄrd U; Bryder D; Nilsson L; Cammenga J
    Leukemia; 2018 May; 32(5):1106-1115. PubMed ID: 29535429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
    Babushok DV; Bessler M
    Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. When to consider inherited marrow failure syndromes in adults.
    Gutierrez-Rodrigues F; Patel BA; Groarke EM
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):548-555. PubMed ID: 38066926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paroxysmal nocturnal hemoglobinuria clones are not infrequent in patients with inherited bone marrow failure syndromes.
    Sreedharanunni S; Varma N; Sachdeva MUS; Naseem S; Malhotra P; Bansal D; Sood A; Bose P; Varma S
    Eur J Haematol; 2017 Aug; 99(2):194-195. PubMed ID: 28452421
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical utility of next-generation sequencing for inherited bone marrow failure syndromes.
    Muramatsu H; Okuno Y; Yoshida K; Shiraishi Y; Doisaki S; Narita A; Sakaguchi H; Kawashima N; Wang X; Xu Y; Chiba K; Tanaka H; Hama A; Sanada M; Takahashi Y; Kanno H; Yamaguchi H; Ohga S; Manabe A; Harigae H; Kunishima S; Ishii E; Kobayashi M; Koike K; Watanabe K; Ito E; Takata M; Yabe M; Ogawa S; Miyano S; Kojima S
    Genet Med; 2017 Jul; 19(7):796-802. PubMed ID: 28102861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two cases showing clonal progression with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia.
    Ishihara S; Nakakuma H; Kawaguchi T; Nagakura S; Horikawa K; Hidaka M; Asou N; Mitsuya H
    Int J Hematol; 2000 Aug; 72(2):206-9. PubMed ID: 11039670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent advances in understanding clonal haematopoiesis in aplastic anaemia.
    Stanley N; Olson TS; Babushok DV
    Br J Haematol; 2017 May; 177(4):509-525. PubMed ID: 28107566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of paroxysmal nocturnal hemoglobinuria clones to exclude inherited bone marrow failure syndromes.
    DeZern AE; Symons HJ; Resar LS; Borowitz MJ; Armanios MY; Brodsky RA
    Eur J Haematol; 2014 Jun; 92(6):467-70. PubMed ID: 24612308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes.
    Wong JC; Bryant V; Lamprecht T; Ma J; Walsh M; Schwartz J; Del Pilar Alzamora M; Mullighan CG; Loh ML; Ribeiro R; Downing JR; Carroll WL; Davis J; Gold S; Rogers PC; Israels S; Yanofsky R; Shannon K; Klco JM
    JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bone marrow cell cycle markers in inherited bone marrow failure syndromes.
    Al-Rahawan MM; Alter BP; Bryant BJ; Elghetany MT
    Leuk Res; 2008 Dec; 32(12):1793-9. PubMed ID: 18606449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats.
    Wang SA; Pozdnyakova O; Jorgensen JL; Medeiros LJ; Stachurski D; Anderson M; Raza A; Woda BA
    Haematologica; 2009 Jan; 94(1):29-37. PubMed ID: 19001281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acquired and Inherited Bone Marrow Failure Syndromes.
    Sieff CA
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):xiii-xiv. PubMed ID: 30047424
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations.
    Hofmann I; Avagyan S; Stetson A; Guo D; Al-Sayegh H; London WB; Lehmann L
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1124-1130. PubMed ID: 32088370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.